COR Cencora Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: COR

Price (delayed)

$227.62

Market cap

$45.4B

P/E Ratio

24.63

Dividend/share

$2.02

EPS

$9.24

Enterprise value

$48.58B

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in ...

Highlights
The equity has increased by 19% from the previous quarter
COR's EPS is up by 17% year-on-year
The company's debt rose by 10% QoQ and by 6% YoY
COR's P/E is 6% above its last 4 quarters average of 23.1
Sector: Healthcare
Industry: Medical Distribution
Website: https://www.amerisourcebergen.com/
Peers: EQIX OLP STWD ALX

Key stats

What are the main financial stats of COR
Market
Shares outstanding
199.45M
Market cap
$45.4B
Enterprise value
$48.58B
Valuations
Price to earnings (P/E)
24.63
Price to book (P/B)
41.92
Price to sales (P/S)
0.16
EV/EBIT
19.21
EV/EBITDA
16.36
EV/Sales
0.18
Earnings
Revenue
$276.54B
EBIT
$2.53B
EBITDA
$2.97B
Free cash flow
$2.11B
Per share
EPS
$9.24
Free cash flow per share
$10.59
Book value per share
$5.43
Revenue per share
$1,386.8
TBVPS
$251.11
Balance sheet
Total assets
$63.87B
Total liabilities
$62.64B
Debt
$5.25B
Equity
$1.08B
Working capital
-$5.6B
Liquidity
Debt to equity
4.85
Current ratio
0.89
Quick ratio
0.5
Net debt/EBITDA
1.07
Margins
EBITDA margin
1.1%
Gross margin
3.4%
Net margin
0.7%
Operating margin
0.9%
Efficiency
Return on assets
2.9%
Return on equity
231.3%
Return on invested capital
93.7%
Return on capital employed
17.9%
Return on sales
0.9%
Dividend
Dividend yield
0.89%
DPS
$2.02
Payout ratio
21.8%

COR stock price

How has the Cencora stock price performed over time
Intraday
0.22%
1 week
1.8%
1 month
-4.07%
1 year
21.26%
YTD
10.83%
QTD
1.03%

Financial performance

How have Cencora's revenue and profit performed over time
Revenue
$276.54B
Gross profit
$9.52B
Operating income
$2.52B
Net income
$1.85B
Gross margin
3.4%
Net margin
0.7%
The operating income has grown by 18% YoY
The company's net income rose by 15% YoY
COR's gross profit is up by 13% year-on-year and by 2.6% since the previous quarter
Cencora's revenue has increased by 12% YoY

Growth

What is Cencora's growth rate over time

Valuation

What is Cencora stock price valuation
COR P/E details
P/E
24.63
P/B
41.92
P/S
0.16
EV/EBIT
19.21
EV/EBITDA
16.36
EV/Sales
0.18
COR's EPS is up by 17% year-on-year
COR's P/E is 6% above its last 4 quarters average of 23.1
The price to book (P/B) is 23% lower than the last 4 quarters average of 54.1
The equity has increased by 19% from the previous quarter
The P/S is 60% above the 5-year quarterly average of 0.1 but 20% below the last 4 quarters average of 0.2
Cencora's revenue has increased by 12% YoY

Efficiency

How efficient is Cencora business performance
The ROE has dropped by 96% year-on-year and by 26% since the previous quarter
Cencora's ROIC has increased by 37% YoY but it has decreased by 10% from the previous quarter
COR's return on sales is down by 10% since the previous quarter
The company's return on assets rose by 3.6% YoY but it fell by 3.3% QoQ

Dividends

What is COR's dividend history
Dividend details
DPS
$2.02
Dividend yield
0.89%
Payout ratio
21.8%
Recent dividends

Financial health

How did Cencora financials performed over time
COR's total assets is up by 9% year-on-year
Cencora's total liabilities has increased by 8% YoY
The debt to equity has dropped by 72% year-on-year and by 7% since the previous quarter
The equity has increased by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.